Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07215702) titled 'A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury' on Oct. 8.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Care Provider, Investigator).
Primary Sponsor: AstraZeneca
Condition:
Sepsis
Acute Kidney Injury
Intervention:
Drug: AZD4144
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollment: December 2, 2025
Target Sample Size: 124
Countries of Recruitment:
United States
Argentina
Belgium
Ca...